Jan Egberts

Dr. Reddy’s launches public to acquire OctoPlus

Dr. Reddy’s launches public to acquire OctoPlusIndia’s leading drug maker, Dr. Reddy’s Laboratories has announced the launch of public offer aiming to raise funds for acquiring all the issued and outstanding shares of Netherlands firm OctoPlus

The company said in a filing with the Bombay Stock exchange (BSE) that that the offer will be closed on February 8, 2013. Dr. Reddy’s has agreed to pay €0.52 a share of Dutch firm OctoPlus.

Syndicate content